News Focus
News Focus
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: aslan2772 post# 975

Thursday, 02/08/2007 1:25:57 PM

Thursday, February 08, 2007 1:25:57 PM

Post# of 2446
>On a related note, SRDX has said they might secure a partner for funding the phase 2 with triamcinolone. This surprised me, because I worry that such a partnership could leverage SRDX into an exclusive license for the delivery platform. Perhaps giving an exclusive is simply the reality of the climate. Thoughts on this?<

If a partner pays for the phase-2 I-vation program, they will probably get an exclusive license on the platform or at worst a co-exclusive license such as the one ANPI has with BSX and Cook. Whether this is a good idea or a bad idea for SRDX depends on the details, but it is IMO probably a bad idea motivated by investors’ preoccupation with short-term EPS.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News